Summarized by Masters of Longevity from Longevity Technology.
Analysis maps 30+ microbiome startups onto longevity themes and examines whether the sector is shifting from wellness tests toward therapeutic interventions.
Key Takeaways
- The microbiome was added as a driver of aging in the hallmarks of aging framework in 2023.
- Diagnostics currently account for over 80% of the microbiome market while therapeutics are the fastest-growing segment.
- Plug and Play Ventures mapped more than 30 companies and highlighted firms using AI to link microbiome profiles with actionable interventions.
